Journal Respiratory Diseases & Treatment最新文献

筛选
英文 中文
Epidemiology of Bronchiolitis: Multicentric Study Policlinico-Garibaldi-Bronte-Caltagirone-Siracusa 细支气管炎流行病学:多中心研究polilinico - garibaldi - bronte - caltagirone - siracusa
Journal Respiratory Diseases & Treatment Pub Date : 2020-04-01 DOI: 10.15744/2767-4649.1.104
B. P.
{"title":"Epidemiology of Bronchiolitis: Multicentric Study Policlinico-Garibaldi-Bronte-Caltagirone-Siracusa","authors":"B. P.","doi":"10.15744/2767-4649.1.104","DOIUrl":"https://doi.org/10.15744/2767-4649.1.104","url":null,"abstract":"","PeriodicalId":430096,"journal":{"name":"Journal Respiratory Diseases & Treatment","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121355364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Salbutamol Nebul Treatment on Systolic Pulmonary Artery Pressure in Newly Diagnosed Patients with Chronic Obstructive Pulmoner Disease 沙丁胺醇胶囊治疗对新诊断慢性阻塞性肺病患者肺动脉收缩压的影响
Journal Respiratory Diseases & Treatment Pub Date : 2020-04-01 DOI: 10.15744/2767-4649.1.102
Cosgun A
{"title":"The Effect of Salbutamol Nebul Treatment on Systolic Pulmonary Artery Pressure in Newly Diagnosed Patients with Chronic Obstructive Pulmoner Disease","authors":"Cosgun A","doi":"10.15744/2767-4649.1.102","DOIUrl":"https://doi.org/10.15744/2767-4649.1.102","url":null,"abstract":"COPD may not only be a functional disorder of the lungs, but may also have systemic effects [1]. Extrapulmonary findings are described in skeletal muscle, bone and cardiovascular system [2]. It is thought that low-intensity chronic inflammation may cause oxidative stress and endothelial dysfunction, thus leading to ischemic heart disease or stroke [3,4]. The occurrence of pulmonary HT in patients with COPD usually indicates progression of the disease and poor prognosis. Pulmonary arterial hypertension [PAH] is diagnosed when mean pulmonary arterial pressure exceeds 25 mm-Hg at rest or 30 mm-Hg during exercise. Right heart catheterization is the gold standard method for measuring pulmonary artery pressure. In addition, echocardiography can be used for this purpose [5]. PAH is present in approximately 50% of patients with COPD, varying according to diagnostic methods [6-9]. The pulmonary artery pressure may increase significantly during exercise, which may lead to an erroneous assessment of exercise capacity. It has been determined that pulmonary artery pressure increases with age in healthy people. However, an increase in pressure in patients with COPD may result in a higher load in the heart and circulation, and reduced exercise tolerance [10-12]. The development of PHT in patients with COPD is an important influence that may transform the disease into pulmonary heart disease [13]. The pathogenesis of PHT in COPD has not yet been clearly elucidated, but it is thought that oxidative stress plays a role [14-18]. Although the negative effect of physical exercise on pulmonary artery pressure in patients with newly diagnosed and untreated COPD is known, its effect on the prognosis of the disease is still unclear [19-22]. The aim of this study is to investigate the effect bronchodilator treatment on systolic pulmonary artery pressure induced by exertion test in patients with COPD. Backround The Effect of Salbutamol Nebul Treatment on Systolic Pulmonary Artery Pressure in Newly Diagnosed Patients with Chronic Obstructive Pulmoner Disease","PeriodicalId":430096,"journal":{"name":"Journal Respiratory Diseases & Treatment","volume":"196 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121108755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features and Management of Eosinophilic Asthma 嗜酸性粒细胞哮喘的临床特点及治疗
Journal Respiratory Diseases & Treatment Pub Date : 2020-04-01 DOI: 10.15744/2767-4649.1.105
S. N.
{"title":"Clinical Features and Management of Eosinophilic Asthma","authors":"S. N.","doi":"10.15744/2767-4649.1.105","DOIUrl":"https://doi.org/10.15744/2767-4649.1.105","url":null,"abstract":"Asthma is a complex chronic airway disease with several distinct phenotypes with different immunopathological pathways, clinical presentation, physiology, cormobidities, biomarker of allergic inflammation, and response to treatment [1-4]. There are several distinct proposed asthma phenotypes, such as childhood-ons et al. lergic asthma, adult-onset eosinophilic asthma,neutrophilic asthma, exercise-induced asthma (EIA), obesity-related asthma, and aspirin-exacerbated respiratory disease (AERD) [5-7]. Severe asthma represents about 5-10% of patients with asthma, and about 50% of these patients present with eosinophilic asthma [8-10]. The guidelines on the definition, evaluation and treatment of severe refractory asthma including eosinophilic asthma are given in detail by thethe American Thoracic Society (ATS) [11], and the European Respiratory Society (ERS) [12]. Severe asthma is defined by the joint ERS/ATS according to the following criteria [12]:","PeriodicalId":430096,"journal":{"name":"Journal Respiratory Diseases & Treatment","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130395983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Predictive Value of ERCC1 Expression on Treatment Response to Cisplatin-Based Regimens in Small Cell Lung Cancer: A Retrospective Analysis ERCC1表达对小细胞肺癌顺铂治疗反应的预测价值:回顾性分析
Journal Respiratory Diseases & Treatment Pub Date : 2020-04-01 DOI: 10.15744/2767-4649.1.103
Arpaci Rb
{"title":"Predictive Value of ERCC1 Expression on Treatment Response to Cisplatin-Based Regimens in Small Cell Lung Cancer: A Retrospective Analysis","authors":"Arpaci Rb","doi":"10.15744/2767-4649.1.103","DOIUrl":"https://doi.org/10.15744/2767-4649.1.103","url":null,"abstract":"","PeriodicalId":430096,"journal":{"name":"Journal Respiratory Diseases & Treatment","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124099644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteoid Osteoma of the Ribs - Is Image Intensifier or Bone Scintigraphy a Mandatory Diagnostic Tool - A Case report with Review of Literature 肋骨骨样骨瘤-影像增强或骨显像是一种强制性的诊断工具-一例报告并文献回顾
Journal Respiratory Diseases & Treatment Pub Date : 2020-04-01 DOI: 10.15744/2767-4649.1.101
Nagre Sw
{"title":"Osteoid Osteoma of the Ribs - Is Image Intensifier or Bone Scintigraphy a Mandatory Diagnostic Tool - A Case report with Review of Literature","authors":"Nagre Sw","doi":"10.15744/2767-4649.1.101","DOIUrl":"https://doi.org/10.15744/2767-4649.1.101","url":null,"abstract":"","PeriodicalId":430096,"journal":{"name":"Journal Respiratory Diseases & Treatment","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134231273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The New Coronavirus (COVID-19) Declared as a Global Pandemic 新型冠状病毒(COVID-19)被宣布为全球大流行
Journal Respiratory Diseases & Treatment Pub Date : 2020-04-01 DOI: 10.15744/2767-4649.1.106
X. J
{"title":"The New Coronavirus (COVID-19) Declared as a Global Pandemic","authors":"X. J","doi":"10.15744/2767-4649.1.106","DOIUrl":"https://doi.org/10.15744/2767-4649.1.106","url":null,"abstract":"","PeriodicalId":430096,"journal":{"name":"Journal Respiratory Diseases & Treatment","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125781569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信